Pathway analysis revealed that modulated SMCs in CAV samples expressed genes related to allograft rejection, antigen presentation, and IFN signaling, while CAD modulated SMCs were enriched in AP-1 and ATF2 transcription factor networks and BDNF signaling pathways (Supplemental 2D). The gene discussed is BDNF; the disease is coronary artery disorder.